Eyenovia

New York, United States

Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.

$10.0M raised

May 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Eyenovia raised?

Eyenovia has raised $10.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in May 2026.

Who are Eyenovia's investors?

Eyenovia's investors include Avenue Capital Group, Armistice Capital, Silicon Valley Bank.

Where is Eyenovia headquartered?

Eyenovia is headquartered in New York, United States.

What does Eyenovia do?

Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.

What stage is Eyenovia at?

Eyenovia is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 6, 2026.

MLA

"Eyenovia — Funding & Investors." VCBacked, May 6, 2026, https://www.vcbacked.co/company/eyenovia. Accessed July 3, 2026.

APA

VCBacked. (2026). Eyenovia — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/eyenovia

Wikipedia (cite web)

{{cite web |title=Eyenovia — Funding & Investors |url=https://www.vcbacked.co/company/eyenovia |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 6, 2026.